Aarti Drugs

65
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE767A01016
  • NSEID: AARTIDRUGS
  • BSEID: 524348
INR
435.00
3.2 (0.74%)
BSENSE

Sep 21, 03:26 PM

BSE+NSE Vol: 1.15 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
2,565.00
2,387.00
2,528.00
2,716.00
2,488.00
2,154.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
2,565.00
2,387.00
2,528.00
2,716.00
2,488.00
2,154.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
19.00
25.00
-1.00
-86.00
-11.00
Raw Materials Consumed
1,595.00
1,496.00
1,626.00
1,863.00
1,750.00
1,310.00
Power & Fuel Cost
174.00
156.00
154.00
155.00
128.00
98.00
Employee Cost
129.00
112.00
102.00
92.00
82.00
80.00
Operating Expenses
245.00
218.00
218.00
192.00
180.00
147.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
78.00
67.00
57.00
69.00
68.00
65.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
16.00
13.00
11.00
10.00
8.00
5.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
2,253.00
2,096.00
2,207.00
2,406.00
2,156.00
1,714.00
Operating Profit (PBDIT) excl Other Income
311.00
290.00
320.00
309.00
332.00
440.00
Other Income
2.00
16.00
4.00
2.00
11.00
4.00
Operating Profit (PBDIT)
314.00
306.00
324.00
311.00
343.00
444.00
Interest
36.00
39.00
37.00
37.00
23.00
26.00
Profit before Depriciation and Tax
277.00
267.00
286.00
274.00
320.00
418.00
Depreciation
66.00
55.00
51.00
50.00
50.00
49.00
Profit Before Taxation & Exceptional Items
210.00
211.00
235.00
224.00
269.00
368.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
210.00
211.00
235.00
224.00
269.00
369.00
Provision for Tax
15.00
43.00
63.00
57.00
64.00
88.00
Profit After Tax
194.00
168.00
171.00
166.00
204.00
280.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
1,240.00
1,155.00
1,020.00
878.00
753.00
591.00
Profit Available for appropriations
1,435.00
1,323.00
1,191.00
1,045.00
958.00
872.00
Appropriations
1,435.00
1,323.00
1,191.00
1,045.00
958.00
872.00
Equity Dividend (%)
20.00%
10.00%
10.00%
10.00%
10.00%
25.00%
Earnings Per Share
21.36
18.35
18.65
17.97
22.12
30.09
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 7.47% vs -5.60% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 7.43% vs -9.54% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -7.02% vs 3.03% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 15.97% vs -2.04% in Mar 2025

Compare Profit and Loss Results of Aarti Drugs
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
2,565.00
944.00
1,621.00
171.72%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
2,565.00
944.00
1,621.00
171.72%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-68.00
68.00
100.00%
Raw Materials Consumed
1,595.00
490.00
1,105.00
225.51%
Power & Fuel Cost
174.00
32.00
142.00
443.75%
Employee Cost
129.00
151.00
-22.00
-14.57%
Operating Expenses
245.00
45.00
200.00
444.44%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
78.00
43.00
35.00
81.40%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
16.00
10.00
6.00
60.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
2,253.00
792.00
1,461.00
184.47%
Operating Profit (PBDIT) excl Other Income
311.00
151.00
160.00
105.96%
Other Income
2.00
2.00
0.00
0.00%
Operating Profit (PBDIT)
314.00
153.00
161.00
105.23%
Interest
36.00
36.00
0.00
0.00%
Profit before Depriciation and Tax
277.00
117.00
160.00
136.75%
Depreciation
66.00
30.00
36.00
120.00%
Profit Before Taxation & Exceptional Items
210.00
86.00
124.00
144.19%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
210.00
86.00
124.00
144.19%
Provision for Tax
15.00
22.00
-7.00
-31.82%
Profit After Tax
194.00
64.00
130.00
203.12%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1,240.00
420.00
820.00
195.24%
Profit Available for appropriations
1,435.00
485.00
950.00
195.88%
Appropriations
1,435.00
485.00
950.00
195.88%
Equity Dividend (%)
20%
10%
10.00
Earnings Per Share
21.36
6.4
14.96
233.75%
Profit And Loss - Net Sales
Net Sales 2,565.31 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 7.47% vs -5.60% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 311.78 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 7.43% vs -9.54% in Mar 2025

Profit And Loss - Interest
Interest 36.30 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -7.02% vs 3.03% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 194.94 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 15.97% vs -2.04% in Mar 2025